Trust Centre
Astellas Pharma
Bayer
Bristol Myers Squibb
Eli Lilly and Company
GSK
Jazz Pharmaceuticals
Johnson & Johnson
Novartis
Regeneron
Roche
Sanofi
Risk Management
Risk Management
We have a dedicated team that manages security risks. We are happy to provide more details about our risk management practices upon request.
Asset Management
Asset Management
We have strict asset management policies in place to ensure that all assets are accounted for and secure.
Subprocessors
Subprocessors
ADVANCE®AI transitions to ISO 27001:2022.
ADVANCE®AI is proud to announce the successful completion of its annual surveillance and transition audit, achieving full certification under ISO/IEC 27001:2022.
This milestone reflects our unwavering commitment to protecting customer data, maintaining robust security controls, and continuously improving our Information Security Management System.
Our renewed certification demonstrates that information security remains embedded in every aspect of how we design, operate, and deliver our platform.
ADVANCE®AI receives its first SOC 2 Type 2 Report.
📢 SOC 2 Type 2 Report now Available
We are pleased to announce that ADVANCE AI Ltd has successfully completed its first SOC 2 Type 2 examination.
This independent assessment validates the effectiveness of our security, availability, and confidentiality controls over an extended period. It provides our customers and partners with further assurance that we operate to the highest standards of information security and compliance.
The full report is now available to authorised users in our Trust Center.